Haemonetics (HAE) Other Non-Current Assets (2010 - 2026)

Haemonetics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $141.7 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 13.63% year-over-year to $141.7 million in Q1 2026; TTM through Mar 2026 was $141.7 million, a 13.63% decrease from a year earlier, with the FY2026 full-year figure at $141.7 million, down 13.63% from the prior year.
• Other Non-Current Assets retreated to $141.7 million in Q1 2026 per HAE's latest filing, from $216.1 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $216.1 million in Q4 2025 and bottomed at $63.2 million in Q2 2022.
• The 5-year median for Other Non-Current Assets is $131.9 million (2023), against an average of $131.8 million.
• Across the five-year window, Other Non-Current Assets jumped 69.25% in 2023 and fell 13.63% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $103.3 million in 2022, then grew by 23.39% to $127.4 million in 2023, then advanced by 25.87% to $160.4 million in 2024, then surged by 34.71% to $216.1 million in 2025, then sank by 34.41% to $141.7 million in 2026.
• Per Business Quant, the three latest HAE Other Non-Current Assets figures stand at $141.7 million (Q1 2026), $216.1 million (Q4 2025), and $208.0 million (Q3 2025).